Joana S. Gomes

Porto, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Targeting cancer cell sialylation with monosaccharide analogues modulates EGFR in colorectal cancer cells.

Targeting cancer cell sialylation with monosaccharide analogues modulates EGFR in colorectal cancer cells.

Journal: Biochimica et biophysica acta. General subjects

Published: February 09, 2026

Immune implications and therapeutic opportunities of tumor glycosylation.

Immune implications and therapeutic opportunities of tumor glycosylation.

Journal: Nature cancer

Published: October 30, 2025

Presentation Is Essential for Glycan-Lectin Recognition at the Molecular and Cellular Levels: The Interaction of Tumor-Associated O‑Glycans with the Macrophage Galactose-Type Lectin.

Presentation Is Essential for Glycan-Lectin Recognition at the Molecular and Cellular Levels: The Interaction of Tumor-Associated O‑Glycans with the Macrophage Galactose-Type Lectin.

Journal: JACS Au

Published: July 21, 2025

Fodinibius alkaliphilus sp. nov., a moderately halophilic and alkaliphilic bacterium isolated from an inland saltern in central Portugal and reclassification of Aliifodinibius salipaludis as Fodinibius salipaludis sp. nov.

Fodinibius alkaliphilus sp. nov., a moderately halophilic and alkaliphilic bacterium isolated from an inland saltern in central Portugal and reclassification of Aliifodinibius salipaludis as Fodinibius salipaludis sp. nov.

Journal: International journal of systematic and evolutionary microbiology

Published: July 09, 2025

Patient-derived organoids to study glycosylation dynamics during gastric disease.

Patient-derived organoids to study glycosylation dynamics during gastric disease.

Journal: Cell reports

Published: March 31, 2025

Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies.

Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies.

Journal: Frontiers in oncology

Published: July 17, 2024

HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches.

HER2 and PD-L1 Expression in Gastric and Gastroesophageal Junction Cancer: Insights for Combinatorial Targeting Approaches.

Journal: Cancers

Published: March 08, 2024

Heterologous expression and structure prediction of a xylanase identified from a compost metagenomic library.

Heterologous expression and structure prediction of a xylanase identified from a compost metagenomic library.

Journal: Applied microbiology and biotechnology

Published: January 10, 2024

Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding.

Plant-derived Durvalumab variants show efficient PD-1/PD-L1 blockade and therapeutically favourable FcR binding.

Journal: Plant biotechnology journal

Published: October 17, 2023

Helicobacter pylori attachment-blocking antibodies protect against duodenal ulcer disease.

Helicobacter pylori attachment-blocking antibodies protect against duodenal ulcer disease.

Journal: bioRxiv : the preprint server for biology

Published: June 09, 2023

Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer.

Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer.

Journal: Acta biomaterialia

Published: January 24, 2023

Corrigendum: Drug-Derived Surface-Active Ionic Liquids: A Cost-Effective Way To Expressively Increase the Blood-Stage Antimalarial Activity of Primaquine.

Corrigendum: Drug-Derived Surface-Active Ionic Liquids: A Cost-Effective Way To Expressively Increase the Blood-Stage Antimalarial Activity of Primaquine.

Journal: ChemMedChem

Published: December 08, 2022

Showing 1-12 of 54

Last Updated: 09/26/2026